From April 1, 2024 to June 30, 2024, the company has repurchased 121,128 shares, representing 0.46% for KRW 459.02 million. With this, the company has completed the repurchase of 774,546 shares, representing 2.9% for KRW 2,999.57 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,545 KRW | +0.71% |
|
+1.87% | -13.75% |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 70.49M | |
+25.40% | 45.54B | |
+34.52% | 24.51B | |
+27.12% | 16.48B | |
+21.19% | 14.66B | |
+71.91% | 14.3B | |
-0.05% | 6.79B | |
-11.84% | 6.73B | |
+18.15% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- A004310 Stock
- News Hyundai Pharmaceutical Co., Ltd.
- Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.